Status:
COMPLETED
Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning
Lead Sponsor:
Bracco Diagnostics, Inc
Conditions:
Radiation Exposure
Eligibility:
All Genders
18+ years
Brief Summary
This study will be performed at clinical sites that have administered CardioGen-82® to patients from January to July 2011. The patients enrolled(i.e., "target date patients") will be all those who wer...
Detailed Description
This clinical study protocol will use a three tier approach consisting of the following examinations: 1. Patient examination with Survey Meter: Patients who agree to be tested at the clinical sites w...
Eligibility Criteria
Inclusion
- Enroll a patient in this study if the patient meets the following inclusion criteria:
- Male or female
- Gave informed consent to participate in the study
- Received CardioGen-82® that had been eluted from the generator on the last usage day the generator was used prior to the generator that was recalled.
Exclusion
- Exclude a patient from this study if the patient has previously been enrolled in and completed this study.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT01424774
Start Date
September 1 2011
End Date
April 1 2012
Last Update
August 15 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bracco Diagnostics, Inc.
Princeton, New Jersey, United States, 08540